$CORT

Corcept Therapeutics Achieves Significant Milestone In Ovarian Cancer Treatment

$CORT Corcept Therapeutics (NASDAQ:CORT) has recently announced a breakthrough in the treatment of platinum-resistant ovarian cancer, marking a significant advancement…